Literature DB >> 15347299

Epidemiology of Helicobacter pylori infection.

Guillermo I Perez-Perez1, Dietrich Rothenbacher, Hermann Brenner.   

Abstract

This review summarizes key results of epidemiologic studies published in peer-reviewed journals between April 2003 and March 2004. The prevalence of H. pylori infection continues to vary strongly between developing countries and developed countries, and according to ethnicity, place of birth and socioeconomic factors among people living in the same country. Intrafamilial spread appears to play a central role in transmission of the infection in both developing and developed countries. The role of H. pylori infection in development of noncardia gastric cancer appears to be even much stronger than previously assumed, whereas the lack of an association with cardia cancer and an inverse association with adenocarcinoma of the esophagus could be confirmed. Suggestions for an inverse association of the infection with atopic diseases have recently received further support, whereas evidence concerning the role of the infection (or its eradication) in GERD and a large variety of other extragastric diseases, including cardiovascular disease, remains inconclusive.

Entities:  

Mesh:

Year:  2004        PMID: 15347299     DOI: 10.1111/j.1083-4389.2004.00248.x

Source DB:  PubMed          Journal:  Helicobacter        ISSN: 1083-4389            Impact factor:   5.753


  63 in total

1.  Ciprofloxacin-containing versus clarithromycin-containing sequential therapy for Helicobacter pylori eradication: A randomized trial.

Authors:  Nabil Ben Chaabane; Hamad Saadoon Al-Adhba
Journal:  Indian J Gastroenterol       Date:  2015-02-28

2.  The utility of the Helicobacter pylori stool antigen test in managing dyspepsia: an experience from a low resource setting.

Authors:  Innocent Lule Segamwenge; Magid Kagimu; Ponsiano Ocama; Kenneth Opio
Journal:  Afr Health Sci       Date:  2014-12       Impact factor: 0.927

Review 3.  Third-line rescue therapy for Helicobacter pylori infection.

Authors:  Rossella Cianci; Massimo Montalto; Franco Pandolfi; Giovan-Battista Gasbarrini; Giovanni Cammarota
Journal:  World J Gastroenterol       Date:  2006-04-21       Impact factor: 5.742

4.  Unique features and risk factors of Helicobacter pylori infection at the main children's intermediate school in Rabigh, Saudi Arabia.

Authors:  Hamed Said Habib; Moustafa Abdelaal Hegazi; Hussam Aly Murad; Elamir Mahmoud Amir; Taher Fawzy Halawa; Basem Salama El-Deek
Journal:  Indian J Gastroenterol       Date:  2014-04-29

5.  Helicobacter pylori: prevalence and relationship with abdominal pain in school children in Makkah City, western Saudi Arabia.

Authors:  Abdulwahab M A Telmesani
Journal:  Saudi J Gastroenterol       Date:  2009-04       Impact factor: 2.485

6.  Body indices and basic vital signs in Helicobacter pylori positive and negative persons.

Authors:  Marcela Kopácová; Jan Bures; Ilona Koupil; Stanislav Rejchrt; Viktor Vorísek; Bohumil Seifert; Oldrich Pozler; Pavel Zivný; Tomás Douda; Vladimír Palicka; Jan Holcík
Journal:  Eur J Epidemiol       Date:  2006-12-29       Impact factor: 8.082

7.  Helicobacter pylori: a poor man's gut pathogen?

Authors:  Mohammed Mahdy Khalifa; Radwa Raed Sharaf; Ramy Karam Aziz
Journal:  Gut Pathog       Date:  2010-03-31       Impact factor: 4.181

8.  The effects of Helicobacter pylori infection on intraocular pressure in anterior uveitis.

Authors:  J M Kim; K H Park; M J Choi; M M Ha; Y H Sohn; H K Kim; J Caprioli
Journal:  Eye (Lond)       Date:  2012-11-16       Impact factor: 3.775

9.  Clinical and endoscopic features of Chinese reflux esophagitis patients.

Authors:  Wei Li; Shu-Tian Zhang; Zhong-Lin Yu
Journal:  World J Gastroenterol       Date:  2008-03-28       Impact factor: 5.742

10.  Ongoing genome reduction in Mycobacterium ulcerans.

Authors:  Simona Rondini; Michael Käser; Timothy Stinear; Michel Tessier; Cyrill Mangold; Gregor Dernick; Martin Naegeli; Françoise Portaels; Ulrich Certa; Gerd Pluschke
Journal:  Emerg Infect Dis       Date:  2007-07       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.